The Bell Perspective

The card-issuing platform's new AI risk score analyzes transactions in milliseconds, aiming to fight advanced fraud while reducing costly false declines.

A new energy firm will drill for oil in Greenland under a legacy permit, clashing with the nation's 2021 ban and setting up a high-stakes environmental fight.

The Diocese of Albany agrees to a $148 million settlement for 440 abuse claims, a major step in its bankruptcy and a victory for survivor advocates.

Ontario's nurses praise new primary and home care funds but warn that cuts to harm reduction and inaction on social issues create a dangerous public health gap.

With a fresh Nasdaq listing and $57.2M in funding, Satellos is advancing a novel muscle-regenerating drug for Duchenne into pivotal pediatric trials.

Just years after mass closures, Metroland is betting on a new monthly print model to revive local journalism and fight misinformation. Is this a new era?

Industry pioneer Andrea MacDonald joins Mediakeys as Americas CEO to drive a major expansion, leveraging proprietary tech in the booming out-of-home market.

In a decisive move to strengthen its balance sheet, the essential minerals firm is using cash on hand to retire debt early, boosting investor confidence.

Pacers Sports & Entertainment launches a first-of-its-kind media network with Deloitte and Yieldmo, turning authenticated fan data into a global ad channel.

The CRDMO giant posted a 16.7% revenue jump in 2025, driven by a massive pipeline expansion and a strategic pivot to next-generation biologics.

A new autonomous AI agent promises to slash tax prep time by 90%, offering a high-tech solution to the accounting industry's critical talent shortage.

Amid new SEC regulations, Armor's new dashboard translates complex cyber threats into dollar terms, giving leaders a real-time, unvarnished look at risk.

VivoPower's CEO converts 2.96M shares to a non-tradable class, reducing public float. What does this bold governance shift mean for investors?

A major distribution shift sees Southern Glazer’s expand its Pernod Ricard deal into TX, LA, and OK, reshaping the competitive landscape for spirits.

With a top award for its Cognitive AI, ThetaRay leads a revolution in how banks fight financial crime, balancing powerful tech with human oversight.

A new oral drug is being tested with existing therapies, offering a two-pronged attack on the glycogen buildup that defines this debilitating rare disease.

The National Bleeding Disorders Foundation taps celebrity power for a live event, aiming to spotlight underdiagnosed conditions and transform advocacy.

SecuriThings' new AI platform moves beyond security to manage all enterprise IoT, promising automated, natural-language fixes for complex device fleets.

A new biotech spins out with a novel drug class aiming to provide healthier, more durable weight loss and combat cancer-related wasting syndrome.

The global trading firm's new OTC offering provides around-the-clock liquidity for tokenized assets, signaling a major shift for institutional trading.